TY - JOUR
T1 - [3H]UR-JG102-A Radiolabeled Cyclic Peptide with High Affinity and Excellent Selectivity for the Neuropeptide Y Y4 Receptor
AU - Gleixner, Jakob
AU - Gattor, Albert O.
AU - Humphrys, Laura J.
AU - Brunner, Thomas
AU - Keller, Max
N1 - Funding Information:
The authors thank Susanne Bollwein, Maria Beer-Krön, and Brigitte Wenzl for excellent technical assistance and Andrea Strasser for fruitful discussions. This work was funded by the Deutsche Forschungsgemeinschaft (DFG) (Graduate Training Program GRK 1910).
Publisher Copyright:
© 2023 American Chemical Society
PY - 2023/10/12
Y1 - 2023/10/12
N2 - The family of human neuropeptide Y receptors (YRs) comprises four subtypes (Y1R, Y2R, Y4R, and Y5R) that are involved in the regulation of numerous physiological processes. Until now, Y4R binding studies have been predominantly performed in hypotonic sodium-free buffers using 125I-labeled derivatives of the endogenous YR agonists pancreatic polypeptide or peptide YY. A few tritium-labeled Y4R ligands have been reported; however, when used in buffers containing sodium at a physiological concentration, their Y4R affinities are insufficient. Based on the cyclic hexapeptide UR-AK86C, we developed a new tritium-labeled Y4R radioligand ([3H]UR-JG102, [3H]20). In sodium-free buffer, [3H]20 exhibits a very low Y4R dissociation constant (Kd 0.012 nM). In sodium-containing buffer (137 mM Na+), the Y4R affinity is lower (Kd 0.11 nM) but still considerably higher compared to previously reported tritiated Y4R ligands. Therefore, [3H]20 represents a useful tool compound for the determination of Y4R binding affinities under physiological-like conditions.
AB - The family of human neuropeptide Y receptors (YRs) comprises four subtypes (Y1R, Y2R, Y4R, and Y5R) that are involved in the regulation of numerous physiological processes. Until now, Y4R binding studies have been predominantly performed in hypotonic sodium-free buffers using 125I-labeled derivatives of the endogenous YR agonists pancreatic polypeptide or peptide YY. A few tritium-labeled Y4R ligands have been reported; however, when used in buffers containing sodium at a physiological concentration, their Y4R affinities are insufficient. Based on the cyclic hexapeptide UR-AK86C, we developed a new tritium-labeled Y4R radioligand ([3H]UR-JG102, [3H]20). In sodium-free buffer, [3H]20 exhibits a very low Y4R dissociation constant (Kd 0.012 nM). In sodium-containing buffer (137 mM Na+), the Y4R affinity is lower (Kd 0.11 nM) but still considerably higher compared to previously reported tritiated Y4R ligands. Therefore, [3H]20 represents a useful tool compound for the determination of Y4R binding affinities under physiological-like conditions.
UR - http://www.scopus.com/inward/record.url?scp=85173606753&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.3c01224
DO - 10.1021/acs.jmedchem.3c01224
M3 - Article
C2 - 37773891
AN - SCOPUS:85173606753
SN - 0022-2623
VL - 66
SP - 13788
EP - 13808
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 19
ER -